Metastatic Urothelial Carcinoma

Study 1 Description

This is a phase 2 study of Gemcitabine plus Cisplatin and Sunitinib in patients with advanced or metastatic Urothelial Carcinoma.

For additional information about Highline's Cancer Care Program, call (206) 439-5577.